Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

16.40
Delayed Data
As of Apr 28
 -0.60 / -3.53%
Today’s Change
7.18
Today|||52-Week Range
17.20
+34.98%
Year-to-Date

Today’s Trading

Previous close17.00
Today’s open15.95
Day’s range15.00 - 16.60
Volume1,114,449
Average volume (3 months)491,512
Market cap$709.2M
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-724.62%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+271.30%
P/E ratio42.1
Price/Sales4.86
Price/Book7.06

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp-0.15-0.91%
AMPHAmphastar Pharmaceut...-0.06-0.40%
ACRSAclaris Therapeutics...-0.71-2.46%
VNDAVanda Pharmaceutical...+0.05+0.33%
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$106.4M
Annual profit (last year)$16.5M
Net profit margin15.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Barabari Sharon A. Surrey
Corporate headquarters
South San Francisco, California

Forecasts